The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Biomodulatory therapy approach with lenalidomide in combination with pioglitazone, dexamethasone, and metronomic low-dose chemotherapy with treosulfan in patients with relapsed/refractory multiple myeloma > second-line.
 
Daniel Heudobler
Travel, Accommodations, Expenses - AAIPharma; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Janssen
 
Tanja Elger
No Relationships to Disclose
 
Stephanie Mayer
No Relationships to Disclose
 
Christina Hart
No Relationships to Disclose
 
Martin Vogelhuber
No Relationships to Disclose
 
Matthias Grube
No Relationships to Disclose
 
Joachim Hahn
No Relationships to Disclose
 
Florian Lüke
No Relationships to Disclose
 
Diana Ditz
Travel, Accommodations, Expenses - Amgen; Celgene; Genzyme; MSD travel grant; Sanofi
 
Andreas Günther
No Relationships to Disclose
 
Martin Gramatzki
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Novartis; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Roche
Research Funding - Amgen; Novartis
Travel, Accommodations, Expenses - Amgen; Celgene; Novartis
 
Burkhard Schmidt
Travel, Accommodations, Expenses - Abbvie; Celgene; Gilead Sciences
 
Peter Ferenczy
No Relationships to Disclose
 
Wolfgang Herr
Travel, Accommodations, Expenses - Amgen; Celgene; Novartis
 
Michael Rechenmacher
No Relationships to Disclose
 
Albrecht Reichle
No Relationships to Disclose